Latest Period
Q1 2026
Security Snapshot
Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX) Institutional Ownership
CUSIP: 92332V107
13F Institutional Holders and Ownership History from Q4 2021 to Q1 2026
Institutions Reporting
1
Shares (Excl. Options)
1,500
Price
$14.00
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, par value $0.0001 per share
- Symbol
- VTYX
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 1,500
- Total 13F value
- $21,000
- Portfolio coverage rank
- 0%
- Share change
- -47,828,006
- Value change
- -$431,873,062
- Number of holders
- 1
- Shares outstanding
- 71,364,430
- SEC-reported price per share
- $14.00
- Insider filing price
- $14.00
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- VTYX - Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share is tracked under CUSIP 92332V107.
- 1 institution reported positions in Q1 2026.
- 13 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 139 to 1 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $471,588,821 to $21,000.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 1 institution filings for Q1 2026.
Security key
92332V107
Latest holder period
Q1 2026
13F holders
1
13D/G owners
13
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 92332V107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
13
Security
VTYX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Affinity Asset Advisors, LLC | 9% | +55% | $58,381,906 | +$21,744,625 | 6,465,041 | +59% | Affinity Asset Advisors, LLC | 22 Jan 2026 |
| NSV Investments I, L.P. | 7.6% | $6,836,036 | 5,425,425 | Somasundaram Subramaniam | 10 Mar 2025 | |||
| GLAZER CAPITAL, LLC | 6.2% | $61,754,996 | 4,446,004 | Glazer Capital, LLC | 12 Feb 2026 | |||
| Mohan Raju | 6% | 0% | $39,622,524 | +$48,060 | 4,387,682 | +0.12% | Raju Mohan | 07 Jan 2026 |
| NSV Partners III LP | 5.7% | $5,153,368 | 4,089,975 | Subramaniam Somu | 28 Mar 2025 | |||
| VANGUARD GROUP INC | 5.3% | $11,725,822 | 3,769,997 | The Vanguard Group | 30 Sep 2025 | |||
| Point72 Asset Management, L.P. | 4.5% | -48% | $9,981,996 | -$8,351,669 | 3,209,645 | -46% | Point72 Asset Management, L.P. | 30 Sep 2025 |
| Sio Capital Management, LLC | 3.6% | -35% | $3,254,145 | -$1,844,819 | 2,582,655 | -36% | Sio Capital Management, LLC | 31 Mar 2025 |
| CITADEL ADVISORS LLC | 2% | $1,776,097 | 1,409,601 | Kenneth Griffin | 31 Mar 2025 | |||
| BlackRock, Inc. | 1.9% | $2,891,112 | 1,350,987 | BlackRock, Inc. | 30 Jun 2025 | |||
| BANK OF AMERICA CORP /DE/ | 1.4% | -73% | $1,280,978 | -$4,535,858 | 1,016,649 | -78% | BANK OF AMERICA CORP /DE/ | 31 Mar 2025 |
| Flynn James E | 0.76% | $673,769 | 534,737 | Deerfield Mgmt, L.P. | 31 Dec 2024 | |||
| MORGAN STANLEY | 0.3% | -95% | $2,143,343 | -$36,594,590 | 237,358 | -94% | Morgan Stanley | 31 Jan 2026 |
As of 31 Mar 2026, 1 institutional investors reported holding 1,500 shares of Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX). This represents 0% of the company’s total 71,364,430 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
18
Latest
Q1 2026
Rows shown
1-18 of 18
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 1,500 | $21,000 | -$431,873,062 | $14.00 | 1 |
| 2025 Q4 | 52,225,382 | $471,588,821 | +$103,493,448 | $9.03 | 139 |
| 2025 Q3 | 43,853,431 | $136,378,109 | -$468,450 | $3.11 | 109 |
| 2025 Q2 | 44,427,101 | $95,066,026 | +$2,059,789 | $2.14 | 112 |
| 2025 Q1 | 44,413,797 | $51,071,272 | -$13,704,510 | $1.15 | 116 |
| 2024 Q4 | 54,449,340 | $119,241,531 | +$4,099,056 | $2.19 | 122 |
| 2024 Q3 | 52,481,458 | $114,411,828 | -$11,847,686 | $2.18 | 115 |
| 2024 Q2 | 57,252,817 | $132,254,360 | -$36,320,827 | $2.31 | 114 |
| 2024 Q1 | 58,990,812 | $323,851,608 | +$111,976,682 | $5.50 | 122 |
| 2023 Q4 | 43,247,569 | $106,821,389 | -$553,553,365 | $2.47 | 118 |
| 2023 Q3 | 54,583,406 | $1,895,690,669 | +$62,410,449 | $34.73 | 137 |
| 2023 Q2 | 52,627,413 | $1,726,219,124 | +$92,758,720 | $32.80 | 146 |
| 2023 Q1 | 49,748,691 | $1,666,552,448 | +$243,592,644 | $33.50 | 143 |
| 2022 Q4 | 42,351,969 | $1,388,715,670 | +$101,470,239 | $32.79 | 122 |
| 2022 Q3 | 39,299,041 | $1,371,090,008 | +$167,335,144 | $34.91 | 104 |
| 2022 Q2 | 34,630,744 | $423,528,800 | +$16,981,526 | $12.23 | 58 |
| 2022 Q1 | 33,233,009 | $448,438,000 | +$21,644,387 | $13.57 | 53 |
| 2021 Q4 | 30,695,789 | $601,183,000 | +$601,183,000 | $19.86 | 45 |